Literature DB >> 9767462

Lack of SC/pIgR-mediated epithelial transport of a human polymeric IgA devoid of J chain: in vitro and in vivo studies.

J P Vaerman1, A Langendries, D Giffroy, P Brandtzaeg, K Kobayashi.   

Abstract

Three human polymeric IgA (pIgA) myeloma proteins of tetrameric size were compared for their J-chain content, their in vitro secretory component (SC)-binding ability, and their capacity to be transcytosed by polymeric immunoglobulin receptor (pIgR)-expressing epithelial cells in vitro and rat hepatocytes in vivo. One of the three pIgA preparations, pIgA-L, was shown to lack J chain and was unable to combine with purified free human and rat SC, whereas pIgA-G and pIgA-C contained J chain and combined readily with SC. Furthermore, pIgA-L was not transferred into rat bile after intravenous injection, and was hardly transported apically by polarized Madin-Darbey canine kidney cell monolayers expressing the human pIgR, whereas pIgA-G and pIgA-C were efficiently transported in both test systems. Together with our recent demonstration that antibodies to human J chain block the SC/pIgR-mediated epithelial transport of pIgA, these data unanimously confirm the proposed key role of J chain in the epithelial transport of polymeric immunoglobulins into exocrine secretions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767462      PMCID: PMC1364381          DOI: 10.1046/j.1365-2567.1998.00560.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Antibody against the human J chain inhibits polymeric Ig receptor-mediated biliary and epithelial transport of human polymeric IgA.

Authors:  J P Vaerman; A E Langendries; D A Giffroy; C S Kaetzel; C M Fiani; I Moro; P Brandtzaeg; K Kobayashi
Journal:  Eur J Immunol       Date:  1998-01       Impact factor: 5.532

2.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

3.  J-chain determinants in polymeric immunoglobulins.

Authors:  K Kobayashi; J P Vaerman; J F Heremans
Journal:  Eur J Immunol       Date:  1973-04       Impact factor: 5.532

4.  A facile method to isolate J-chain from polymeric serum IgA or IgM.

Authors:  K Kobayashi; J P Vaerman; J F Heremans
Journal:  Immunochemistry       Date:  1974-03

5.  Improved procedure for the isolation of J-chain from human polymeric immunoglobulins.

Authors:  K Kobayashi; J P Vaerman; J F Heremans
Journal:  Biochim Biophys Acta       Date:  1973-03-23

6.  Complex formation between secretory component and human immunoglobulins related to their content of J chain.

Authors:  P Brandtzaeg
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

7.  Selective proteolysis of the J chain component in human polymeric immunoglobulin.

Authors:  M E Koshland; R M Chapuis; B Recht; J C Brown
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

8.  Stabilization of dissociable IgA2 proteins by secretory component.

Authors:  L M Jerry; H G Kunkel; L Adams
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

9.  Naturally occurring polymers of IgA lacking J chain.

Authors:  T B Tomasi; D S Czerwinski
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

10.  Blocking effect of J chain and J-chain antibody on the binding of secretory component to human IgA and IgM.

Authors:  P Brandtzaeg
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

View more
  11 in total

1.  Expression, purification and biochemical characterization of recombinant murine secretory component: a novel tool in mucosal immunology.

Authors:  P Crottet; S Cottet; B Corthésy
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

Review 2.  The role of secretory antibodies in infection immunity.

Authors:  Richard A Strugnell; Odilia L C Wijburg
Journal:  Nat Rev Microbiol       Date:  2010-08-09       Impact factor: 60.633

3.  Site-specific glycosylation of secretory immunoglobulin A from human colostrum.

Authors:  Jincui Huang; Andres Guerrero; Evan Parker; John S Strum; Jennifer T Smilowitz; J Bruce German; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2015-02-11       Impact factor: 4.466

4.  Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins.

Authors:  Isabelle Schwartz-Cornil; Yann Benureau; Harry Greenberg; Barbara A Hendrickson; Jean Cohen
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

5.  Simplifying the synthesis of SIgA: combination of dIgA and rhSC using affinity chromatography.

Authors:  Brian Moldt; Karen Saye-Francisco; Niccole Schultz; Dennis R Burton; Ann J Hessell
Journal:  Methods       Date:  2013-06-25       Impact factor: 3.608

6.  Comparison of FcRn- and pIgR-mediated transport in MDCK cells by fluorescence confocal microscopy.

Authors:  Galina V Jerdeva; Devin B Tesar; Kathryn E Huey-Tubman; Mark S Ladinsky; Scott E Fraser; Pamela J Bjorkman
Journal:  Traffic       Date:  2010-05-26       Impact factor: 6.215

7.  Fecal Proteomic Analysis in Healthy Dogs and in Dogs Suffering from Food Responsive Diarrhea.

Authors:  Matteo Cerquetella; Giacomo Rossi; Andrea Spaterna; Beniamino Tesei; Alessandra Gavazza; Graziano Pengo; Stefania Pucciarelli; Luca Scortichini; Gianni Sagratini; Massimo Ricciutelli; Andrea Marchegiani; Silvia Vincenzetti
Journal:  ScientificWorldJournal       Date:  2019-01-03

Review 8.  The B-cell system of human mucosae and exocrine glands.

Authors:  P Brandtzaeg; I N Farstad; F E Johansen; H C Morton; I N Norderhaug; T Yamanaka
Journal:  Immunol Rev       Date:  1999-10       Impact factor: 12.988

Review 9.  Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis.

Authors:  Hao Wei; Ji-Yang Wang
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

10.  Targeting mucosal sites by polymeric immunoglobulin receptor-directed peptides.

Authors:  Kendra D White; J Donald Capra
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.